<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><description>It takes nothing to join the crowd, but it takes everything to stand alone</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 27 Feb 2021 07:32:32 +0800</pubDate><image><url>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</url><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>【CDE文章】多规格口服固体制剂仿制药生物豁免的药学考虑</title><link>https://mp.weixin.qq.com/s/uEqq_OfiYFjSHOpuznIZuA</link><description></description><content:encoded><![CDATA[【CDE文章】多规格口服固体制剂仿制药生物豁免的药学考虑]]></content:encoded><pubDate>Fri, 26 Feb 2021 23:13:28 +0800</pubDate></item><item><title>【周立春】工艺变更申报与注册工艺核查的政策解读</title><link>https://mp.weixin.qq.com/s/qm8U8alrczQhBwC24VDYkQ</link><description></description><content:encoded><![CDATA[【周立春】工艺变更申报与注册工艺核查的政策解读]]></content:encoded><pubDate>Fri, 26 Feb 2021 23:13:28 +0800</pubDate></item><item><title>【百科】“漫说”干细胞神奇在哪里？</title><link>https://mp.weixin.qq.com/s/esTrtlI9CSgs_AbmYtB-AA</link><description></description><content:encoded><![CDATA[【百科】“漫说”干细胞神奇在哪里？]]></content:encoded><pubDate>Fri, 26 Feb 2021 23:13:28 +0800</pubDate></item><item><title>双抗时代，渐入佳境</title><link>https://mp.weixin.qq.com/s/AP_dayjSy7__2INy-CFiMQ</link><description></description><content:encoded><![CDATA[双抗时代，渐入佳境]]></content:encoded><pubDate>Thu, 25 Feb 2021 20:17:46 +0800</pubDate></item><item><title>免疫NK细胞是抗癌的主力军</title><link>https://mp.weixin.qq.com/s/TCurRZfxyOF6QKlUZCOhLw</link><description></description><content:encoded><![CDATA[免疫NK细胞是抗癌的主力军]]></content:encoded><pubDate>Thu, 25 Feb 2021 20:17:46 +0800</pubDate></item><item><title>【速递】CDE发布《放射性体内诊断药物非临床研究技术指导原则》</title><link>https://mp.weixin.qq.com/s/sTn_NGZIP9bqdjPRgNESiA</link><description></description><content:encoded><![CDATA[【速递】CDE发布《放射性体内诊断药物非临床研究技术指导原则》]]></content:encoded><pubDate>Thu, 25 Feb 2021 20:17:46 +0800</pubDate></item><item><title>干细胞为脑出血后遗症患者带来希望</title><link>https://mp.weixin.qq.com/s/oahUiY-AvL8xfaAS7hipPQ</link><description></description><content:encoded><![CDATA[干细胞为脑出血后遗症患者带来希望]]></content:encoded><pubDate>Wed, 24 Feb 2021 19:39:39 +0800</pubDate></item><item><title>药物共晶的筛选制备及溶解行为研究进展</title><link>https://mp.weixin.qq.com/s/q6a3-nRFX8ZCp902VHlWeQ</link><description></description><content:encoded><![CDATA[药物共晶的筛选制备及溶解行为研究进展]]></content:encoded><pubDate>Wed, 24 Feb 2021 19:39:39 +0800</pubDate></item><item><title>国家药监局关于发布《已上市中药变更事项及申报资料要求》的通告</title><link>https://mp.weixin.qq.com/s/vDRWkZiVLXdUmPMfKv6SxQ</link><description></description><content:encoded><![CDATA[国家药监局关于发布《已上市中药变更事项及申报资料要求》的通告]]></content:encoded><pubDate>Wed, 24 Feb 2021 19:39:39 +0800</pubDate></item><item><title>刚刚！第三款国产新冠疫苗，康希诺「Ad5-nCoV」上市申请获受理</title><link>https://mp.weixin.qq.com/s/D4-x1cYdAKIpp1OZp9nCyA</link><description></description><content:encoded><![CDATA[刚刚！第三款国产新冠疫苗，康希诺「Ad5-nCoV」上市申请获受理]]></content:encoded><pubDate>Wed, 24 Feb 2021 19:39:39 +0800</pubDate></item><item><title>好消息来了！119种降价药品纳入医保</title><link>https://mp.weixin.qq.com/s/m01eYeEWVI_yQliZbFHQ3A</link><description></description><content:encoded><![CDATA[好消息来了！119种降价药品纳入医保]]></content:encoded><pubDate>Wed, 24 Feb 2021 19:39:39 +0800</pubDate></item><item><title>特殊注射剂的仿制（PPT）</title><link>https://mp.weixin.qq.com/s/nRXdBEvQbZZg2ouDnnPjIQ</link><description></description><content:encoded><![CDATA[特殊注射剂的仿制（PPT）]]></content:encoded><pubDate>Tue, 23 Feb 2021 21:11:58 +0800</pubDate></item><item><title>重磅！CDE发布《药审中心技术审评报告公开工作规范（试行）》涉及“商业秘密”“部分，务必认真读！</title><link>https://mp.weixin.qq.com/s/bkBmzCoP83C10ZTOSJElvA</link><description></description><content:encoded><![CDATA[重磅！CDE发布《药审中心技术审评报告公开工作规范（试行）》涉及“商业秘密”“部分，务必认真读！]]></content:encoded><pubDate>Tue, 23 Feb 2021 21:11:58 +0800</pubDate></item><item><title>CDE：关于公开征求《基因修饰细胞治疗产品非临床研究与评价技术指导原则》（试行）意见的通知</title><link>https://mp.weixin.qq.com/s/54oPEQlco7HdKrmT7cW-3A</link><description></description><content:encoded><![CDATA[CDE：关于公开征求《基因修饰细胞治疗产品非临床研究与评价技术指导原则》（试行）意见的通知]]></content:encoded><pubDate>Tue, 23 Feb 2021 21:11:58 +0800</pubDate></item><item><title>【上海】2021药物非临床安全评价关键技术专题培训班</title><link>https://mp.weixin.qq.com/s/Ih-w5ZgoTBtr3WDwRoY_8w</link><description></description><content:encoded><![CDATA[【上海】2021药物非临床安全评价关键技术专题培训班]]></content:encoded><pubDate>Tue, 23 Feb 2021 21:11:58 +0800</pubDate></item><item><title>新冠疫苗养成记：一支疫苗的前世今生</title><link>https://mp.weixin.qq.com/s/M1lGXgMqsyMr8j2LZMA7zw</link><description></description><content:encoded><![CDATA[新冠疫苗养成记：一支疫苗的前世今生]]></content:encoded><pubDate>Mon, 22 Feb 2021 18:59:29 +0800</pubDate></item><item><title>【干货】如何做好工艺验证&amp;清洁验证&amp;分析方法验证</title><link>https://mp.weixin.qq.com/s/Q7a_lx0zZu3pCWQa9Wk--A</link><description></description><content:encoded><![CDATA[【干货】如何做好工艺验证&清洁验证&分析方法验证]]></content:encoded><pubDate>Mon, 22 Feb 2021 18:59:29 +0800</pubDate></item><item><title>CDK4/6抑制剂的江湖，新药还是仿药的抉择</title><link>https://mp.weixin.qq.com/s/mZIAOyRZHXv8sv9Cux6hkw</link><description></description><content:encoded><![CDATA[CDK4/6抑制剂的江湖，新药还是仿药的抉择]]></content:encoded><pubDate>Mon, 22 Feb 2021 18:59:29 +0800</pubDate></item><item><title>严重副作用不同疾病的对应手册（面向患者·公众）（56）-间质性肺炎</title><link>https://mp.weixin.qq.com/s/LUTgSsqY4827a4Wco59Jjg</link><description></description><content:encoded><![CDATA[严重副作用不同疾病的对应手册（面向患者·公众）（56）-间质性肺炎]]></content:encoded><pubDate>Sun, 21 Feb 2021 21:14:20 +0800</pubDate></item><item><title>漫画 | 从一粒药的研发过程解读相关专业</title><link>https://mp.weixin.qq.com/s/s44QoZ6dXsLRkUoP4dMOSQ</link><description></description><content:encoded><![CDATA[漫画 | 从一粒药的研发过程解读相关专业]]></content:encoded><pubDate>Sun, 21 Feb 2021 21:14:20 +0800</pubDate></item></channel></rss>